Skip to content
French WebsiteFrench WebsiteLinkedIn
Halo Pharmaceuticals Logo Halo Pharmaceuticals Logo Halo Pharmaceuticals Logo
  • Capabilities
    • Formulation Development
    • Clinical Manufacturing
    • Commercial Manufacturing
    • Dosage Types
      • Solid Dosage
      • Fixed-Dose Combinations
      • Pediatric
      • Liquids
      • Topicals
      • Semi-Solid Dosage
    • Analytical Services
    • Packaging
  • How We Help
    • Large Pharma
    • Specialty Pharma
    • Generics
  • Facilities
    • Whippany, NJ
      • Regulatory History
      • Controlled Substances
    • Montreal, CA
      • Regulatory History
      • Controlled Substances
    • Schedule a Tour
  • Knowledge Center
    • Whitepapers
    • Case Studies
    • Brochures
  • About
    • Company Overview
    • Leadership
    • Events
    • News
    • Affiliations
  • Contact

News

Newsdigitalmettle2018-07-03T13:29:18+00:00
digitalmettle2018-07-03T13:51:13+00:00

Halo Pharma Simplifies Topical Drug Product Development and Manufacturing

digitalmettle2018-07-03T13:51:13+00:00April 12th, 2018|

Halo Pharma Simplifies Topical Drug Product Development and Manufacturing Global Pharmaceutical Companies Outsource Topical Products to Halo Pharma Whippany, N.J., April 12, 2018 – Halo Pharma, a rapidly growing contract development and manufacturing organization Read More

digitalmettle2018-07-03T13:49:52+00:00

Halo Pharma Shares Expertise on Fixed-Dose Combination Products as an Effective Approach to Simplified Dosing

digitalmettle2018-07-03T13:49:52+00:00April 5th, 2018|

Halo Pharma Shares Expertise on Fixed-Dose Combination Products as an Effective Approach to Simplified Dosing Anthony Qu, PhD, Vice President Scientific Affairs, Presents at CPhI NA Whippany, NJ, April 5, 2018 – Halo Pharma Read More

digitalmettle2018-07-03T13:48:49+00:00

Halo Pharma Partners with Pharmaceutical Companies to Formulate and Manufacture a Broad Range of Fixed-Dose Combination Drug Products

digitalmettle2018-07-03T13:48:49+00:00November 2nd, 2017|

Halo-Produced FDC Drugs Already Approved and in Development Benefit Patients, Reduce Costs, and Can Extend Patent Life and Market Dominance Whippany, NJ, November 2, 2017 - Halo Pharma ("Halo") provides its pharmaceutical manufacturing partners Read More

digitalmettle2018-07-03T13:46:31+00:00

Halo Pharma Makes Donation to the American Red Cross and Encourages Others to Help Those Affected by Hurricanes Harvey and Irma

digitalmettle2018-07-03T13:46:31+00:00September 12th, 2017|

Halo Pharma (“Halo”) has made a donation to the American Red Cross to support the humanitarian organization's ongoing efforts to provide emergency aid and disaster relief for the people affected by Hurricane Harvey and Read More

digitalmettle2018-07-03T13:44:46+00:00

Halo Pharma Welcomes Itzhak Krinsky, Ph.D. to Its Board of Directors

digitalmettle2018-07-03T13:44:46+00:00June 26th, 2017|

Halo Pharma Welcomes Itzhak Krinsky, Ph.D. to Its Board of Directors Whippany, NJ - Halo Pharma, a rapidly growing Contract Development and Manufacturing Organization (CDMO), is pleased to announce that Dr. Itzhak Krinsky has Read More

digitalmettle2018-07-03T13:42:25+00:00

Halo Pharma’s Pediatric Center of Excellence

digitalmettle2018-07-03T13:42:25+00:00May 10th, 2017|

Whippany, NJ, May 10, 2017 - Halo Pharma announces the formation of its Pediatric Center of Excellence in support of the development and manufacture of dosage forms tailored for pediatric indications. Halo Pharma has Read More

Previous123Next

Careers

See All Job Openings

Contact Us

30 North Jefferson Road
Whippany, NJ 07981, USA
Tel: (866) 888-4256 (HALO)

17800, rue Lapointe
Mirabel, Québec J7J 0W8, Canada
Tel: 450-433-7673

Site Map

Capabilities
How We Help
Facilities
Schedule a Tour
Knowledge Center
About Halo
Contact
Careers
Events
News

© 2018 Halo Pharma. All Rights Reserved

SBA Seal
  • Privacy Policy
  • Terms and Conditions
  • Sitemap

Designed by Brandwidth Solutions